ICYMI—New antibody treatment reduces number of new abnormal bone lesions by at least 90% in people with ultra-rare genetic disorder, fibrodysplasia ossificans progressiva (FOP), phase 3 study shows. Read now: spkl.io/633227X6ri

Show Post

My former @upenn.edu PhD student who defended her thesis a couple of years ago, Eileen Goodwin, was on @jeopardyofficial.bsky.social last night and won! She ironically missed a question about antigens, but we will cut her some slack because she was amazing! Congrats Eileen!

Show Post

A terrible loss.

Show Post

I worked with—and deeply admired—Helen for almost 30 years. She was hands down *the best source* about emerging infectious diseases that I've ever known. My first warning of COVID was when on Dec 28, 2019 she reposted a ProMED mail report of an atypical pneumonia cluster: "This doesn't look good."

Show Post

She was an exceptional reporter, curious scientist, and all-around wonderful person. I cannot begin to describe the magnitude of this loss for science, public health, and global understanding of disease. We'll miss you enormously, Helen.

Show Post